JAK2, Janus kinase 2
Integrated in Silico Docking and MoMA Simulation Methods Reveal Rottlerin as a Potent Janus kinase 2 (JAK2) Inhibitor
... Janus kinase 2 (JAK2) is a prospective drug target for myeloproliferative neoplasms, mainly polycythemia Vera, essential thrombocythemia and primary myelofibrosis ...disorders. JAK2 ...
10
Pharmacophore generation and atom based 3D QSAR analysis of substituted aromatic bicyclic compounds containing pyrimidine and pyridine rings as Janus kinase 2 (JAK2) inhibitors
... Janus kinase 2 plays a critical role in JAK/STAT signaling pathways, and has a central role in cell ...cycle. JAK2 have emerged as a novel therapeutic target of myeloproliferative disorders, ...
7
Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor negative breast cancer via Src family kinase mediated, janus kinase 2 independent pathway
... glucuronidase; JAK2: janus kinase 2; LEPR: leptin receptor; LEPR-Long: longest isoform of LEPR; LN: lymph node; MRPL19: mitochondrial ribosomal protein L19; MTT: ...
15
Download Download PDF
... in JAK2 gene had an impact on higher RBC and Hb values (*) compared to CALR-mutated patients and MPL mutation had an impact on higher Plt values (**) compared to JAK2-mutated ...MPNs; JAK2: ...
12
A case of minor BCR-ABL1 positive acute lymphoblastic leukemia following essential thrombocythemia and originating from a clone distinct from that harboring the JAK2-V617F mutation
... thrombocythemia; JAK2: Janus Kinase 2; HSPCs: Hematopoietic stem and progenitor cells; MPNs: Myeloproliferative neoplasms; PV: Polycythemia vera; PMF: Primary myelofibrosis; AML: Acute myeloid ...
5
JAK2 Mutations in Chronic Myeloproliferative Neoplasm; Towards the Application of Personalized Treatments for Saudi Patients
... tyrosine kinase activity of the chimeric ...the Janus kinase 2 gene (JAK2), causes a valine to phenylalanine substitution at position 617 (JAK2 V617F) resulting in a ...
5
Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor
... of Janus kinase 2 (JAK2), JAK2V617F, and fms-like receptor tyrosine kinase 3, is in Phase III development in ...inhibit JAK2/signal transducer and activator of transcription 3 ...
9
Splenomegaly in myelofibrosis—new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors
... in JAK2 and mutations involving the thrombopoietin re- ceptor (TPO-r or myeloproliferative leukemia, MPL, oncogene) have also been implicated in the etiology and symptomatology of MF, PV, and ET ...Several ...
7
A highly selective, orally active inhibitor of Janus kinase 2, CEP 33779, ablates disease in two mouse models of rheumatoid arthritis
... file 2, Figure S2C) ...file 2, Figure ...upon JAK2 inhibitor treatment resulted in reduced bone degradation, reduced tissue destruction, and reduced osteoarthritis as evidenced by the histopathology ...
15
Combination of the ABL kinase inhibitor imatinib with the Janus kinase 2 inhibitor TG101348 for targeting residual BCR-ABL-positive cells
... the JAK2/ STAT5 pathway [27]. We demonstrated that inhibiting JAK2 by either JAK2 siRNA transfection or the JAK2 in- hibitor TG101348 downregulated STAT5 ...proliferation. JAK2 ...
11
Biologically inactive growth hormone caused by an amino acid substitution
... site 2 of the GH molecule in bind- ing with GH receptor (GHR)/GH binding protein ...GHR, janus kinase 2 (JAK2), and signal transducers and activators of transcription 5 (STAT5) in IM-9 ...
8
α Lipoic Acid Inhibits Expression of IL 8 by Suppressing Activation of MAPK, Jak/Stat, and NF κB in H pylori Infected Gastric Epithelial AGS Cells
... for 2 h and cultured in the presence of ...Jak1, Jak2, Stat3 (D) in whole cell lysates were determined by Western blot ...signal-regulated kinase; JNK, c-Jun NH 2 -terminal protein ...
5
In silico docking analysis of Janus kinase enzymes and phytochemicals
... and JAK2) inhibitor, is frequently prescribed to treat patients with myelofibroses to reduce inflammatory ...JAK 2 and JAK 3) for the development of safe and effective anti-inflammatory drugs using in ...
7
Role of janus kinase inhibitors in the treatment of alopecia areata
... receptor, janus kinase (JAK), and signal transducer and activator of transcription (STAT) (Figure ...tyrosine kinase family, which consists of JAK1, JAK2, JAK3, and tyrosine kinase ...
13
<p>NVP-BSK805, an Inhibitor of JAK2 Kinase, Significantly Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma in vitro and in vivo</p>
... molecular kinase inhibitors had the ability to restrain tumor growth and enhance tumor response to ...Several kinase inhibitors such as tyrosine/ phosphoinositide kinase inhibitor PP121 signi fi ...
11
Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2
... of Janus kinase (JAK)2 (4), which then phosphor- ylates GHRs and the signal transducers and activators of transcrip- tion (STATs), including STAT1, -3, and -5 ...
7
Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma
... protein kinase; JAK – STAT: Janus Kinase/Signal Transducer and Activator of Transcription; JNK: cJun N-terminal kinase; LMP-1: Epstein-Barr Virus -encoded latent membrane protein-1; NF- κ B: ...
7
Leptin signaling molecular actions and drug target in hepatocellular carcinoma
... classes of neutralizing nanobodies targeting different Ob-R subdomains, ie, the Ig-like and fibronectin type III domains and cytokine receptor homology 2, were identified. Among them, only nanobodies directed ...
8
Somatic CALR Mutations in myeloproliferative neoplasms with nonmutated JAK2
... We thank members of the Cambridge Blood and Stem Cell Bank (Cambridge), Tayside Cancer Tissue Bank (Dundee), and Haemato- Oncology Diagnostics Laboratory, Addenbrooke’s Hospital (Cam- bridge) for technical assistance; ...
16
Tocotrienols fight cancer by targeting multiple cell signaling pathways
... Abstract Cancer cells are distinguished by several dis- tinct characteristics, such as self-sufficiency in growth signal, resistance to growth inhibition, limitless replicative potential, evasion of apoptosis, sustained ...
10